{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T10:23:44Z","timestamp":1697106224609},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T00:00:00Z","timestamp":1120694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T00:00:00Z","timestamp":1120694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1038\/sj.gt.3302502","type":"journal-article","created":{"date-parts":[[2005,7,21]],"date-time":"2005-07-21T09:48:31Z","timestamp":1121939311000},"page":"1235-1241","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Local immunomodulation with CD4 and CD8 antibodies, but not cyclosporine A, improves osteogenesis induced by ADhBMP9 gene therapy"],"prefix":"10.1038","volume":"12","author":[{"given":"J Z","family":"Li","sequence":"first","affiliation":[]},{"given":"H","family":"Li","sequence":"additional","affiliation":[]},{"given":"G R","family":"Hankins","sequence":"additional","affiliation":[]},{"given":"B","family":"Dunford","sequence":"additional","affiliation":[]},{"given":"G A","family":"Helm","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2005,7,7]]},"reference":[{"issue":"Suppl 1","key":"BF3302502_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1600-0722.1998.tb02170.x","volume":"106","author":"JM Wozney","year":"1998","unstructured":"Wozney JM . The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult. Eur J Oral Sci 1998; 106 (Suppl 1): 160\u2013166.","journal-title":"Eur J Oral Sci"},{"key":"BF3302502_CR2","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1046\/j.1523-1755.2000.00081.x","volume":"57","author":"P Ducy","year":"2000","unstructured":"Ducy P, Karsenty G . The family of bone morphogenetic proteins. Kidney Int 2000; 57: 2207\u20132214.","journal-title":"Kidney Int"},{"key":"BF3302502_CR3","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nbt864","volume":"21","author":"M Nakashima","year":"2003","unstructured":"Nakashima M, Reddi AH . The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol 2003; 21: 1025\u20131032.","journal-title":"Nat Biotechnol"},{"key":"BF3302502_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3171\/jns.2003.98.1.0125","volume":"98","author":"JP Sheehan","year":"2003","unstructured":"Sheehan JP et al. The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model. J Neurosurg 2003; 98: 125\u2013130.","journal-title":"J Neurosurg"},{"issue":"Suppl 1","key":"BF3302502_CR5","first-page":"S161","volume":"83-A","author":"SD Boden","year":"2001","unstructured":"Boden SD . Clinical application of the BMPs. J Bone Joint Surg Am 2001; 83-A (Suppl 1): S161.","journal-title":"J Bone Joint Surg Am"},{"key":"BF3302502_CR6","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/sj.gt.3302075","volume":"10","author":"JZ Li","year":"2003","unstructured":"Li JZ et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Therapy 2003; 10: 1735\u20131743.","journal-title":"Gene Therapy"},{"key":"BF3302502_CR7","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2106\/00004623-200308000-00017","volume":"85-A","author":"H Cheng","year":"2003","unstructured":"Cheng H et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85-A: 1544\u20131552.","journal-title":"J Bone Joint Surg Am"},{"key":"BF3302502_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/sj.gt.3301999","volume":"10","author":"Y Chen","year":"2003","unstructured":"Chen Y et al. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Therapy 2003; 10: 1345\u20131353.","journal-title":"Gene Therapy"},{"key":"BF3302502_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1302\/0301-620X.84B1.11708","volume":"84","author":"DS Musgrave","year":"2002","unstructured":"Musgrave DS et al. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br 2002; 84: 120\u2013127.","journal-title":"J Bone Joint Surg Br"},{"key":"BF3302502_CR10","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1089\/10430349950017220","volume":"10","author":"TD Alden","year":"1999","unstructured":"Alden TD et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 1999; 10: 2245\u20132253.","journal-title":"Hum Gene Ther"},{"key":"BF3302502_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/sj.gt.3302176","volume":"11","author":"S Kaihara","year":"2004","unstructured":"Kaihara S et al. Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 mixture in rats. Gene Therapy 2004; 11: 439\u2013447.","journal-title":"Gene Therapy"},{"key":"BF3302502_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0024-3205(01)01393-5","volume":"70","author":"Y Okubo","year":"2001","unstructured":"Okubo Y et al. The time course study of osteoinduction by bone morphogenetic protein-2 via adenoviral vector. Life Sci 2001; 70: 325\u2013336.","journal-title":"Life Sci"},{"issue":"Suppl 1","key":"BF3302502_CR13","first-page":"42","volume":"32","author":"RG Russell","year":"1993","unstructured":"Russell RG, Graveley R, Skjodt H . The effects of cyclosporin A on bone and cartilage. Br J Rheumatol 1993; 32 (Suppl 1): 42\u201346.","journal-title":"Br J Rheumatol"},{"key":"BF3302502_CR14","first-page":"108","volume":"20","author":"JC Hong","year":"2000","unstructured":"Hong JC, Kahan BD . Immunosuppressive agents in organ transplantation: past, present, and future. Semin Nephrol 2000; 20: 108\u2013125.","journal-title":"Semin Nephrol"},{"key":"BF3302502_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1006\/mthe.2002.0691","volume":"6","author":"JA Jane Jr","year":"2002","unstructured":"Jane Jr JA et al. Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 2002; 6: 464\u2013470.","journal-title":"Mol Ther"},{"key":"BF3302502_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/jgm.412","volume":"5","author":"JZ Li","year":"2003","unstructured":"Li JZ et al. Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus. J Gene Med 2003; 5: 748\u2013756.","journal-title":"J Gene Med"},{"key":"BF3302502_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/0049-0172(92)90009-3","volume":"21","author":"G Russell","year":"1992","unstructured":"Russell G et al. Mechanisms of action of cyclosporine and effects on connective tissues. Semin Arthritis Rheum 1992; 21: 16\u201322.","journal-title":"Semin Arthritis Rheum"},{"key":"BF3302502_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/03009749209101478","volume":"95","author":"RG Russell","year":"1992","unstructured":"Russell RG et al. Cyclosporin A. Mode of action and effects on bone and joint tissues. Scand J Rheumatol Suppl 1992; 95: 9\u201318.","journal-title":"Scand J Rheumatol Suppl"},{"key":"BF3302502_CR19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ymthe.2003.08.013","volume":"8","author":"JZ Li","year":"2003","unstructured":"Li JZ et al. Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenoviruses. Mol Ther 2003; 8: 822\u2013829.","journal-title":"Mol Ther"},{"key":"BF3302502_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cellsig.2003.08.011","volume":"16","author":"A Nohe","year":"2004","unstructured":"Nohe A, Keating E, Knaus P, Petersen NO . Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004; 16: 291\u2013299.","journal-title":"Cell Signal"},{"key":"BF3302502_CR21","doi-asserted-by":"publisher","first-page":"17937","DOI":"10.1074\/jbc.275.24.17937","volume":"275","author":"AF Miller","year":"2000","unstructured":"Miller AF, Harvey SA, Thies RS, Olson MS . Bone morphogenetic protein-9. An autocrine\/paracrine cytokine in the liver. J Biol Chem 2000; 275: 17937\u201317945.","journal-title":"J Biol Chem"},{"key":"BF3302502_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0928-4257(01)00080-8","volume":"96","author":"I Lopez-Coviella","year":"2002","unstructured":"Lopez-Coviella I, Berse B, Thies RS, Krzysztof Blusztajn J . Upregulation of acetylcholine synthesis by bone morphogenetic protein 9 in a murine septal cell line. J Physiol Paris 2002; 96: 53\u201359.","journal-title":"J Physiol Paris"},{"key":"BF3302502_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1089\/104303401300057423","volume":"12","author":"P Varady","year":"2001","unstructured":"Varady P et al. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 2001; 12: 697\u2013710.","journal-title":"Hum Gene Ther"},{"key":"BF3302502_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S8756-3282(01)00428-8","volume":"28","author":"GR Goodman","year":"2001","unstructured":"Goodman GR et al. Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss. Bone 2001; 28: 583\u2013588.","journal-title":"Bone"},{"key":"BF3302502_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S8756-3282(99)00182-9","volume":"25","author":"GR Goodman","year":"1999","unstructured":"Goodman GR et al. Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the rat. Bone 1999; 25: 459\u2013463.","journal-title":"Bone"},{"key":"BF3302502_CR26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1210\/endo.135.3.8070349","volume":"135","author":"GN Mann","year":"1994","unstructured":"Mann GN et al. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology 1994; 135: 1077\u20131083.","journal-title":"Endocrinology"},{"key":"BF3302502_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/ard.61.6.511","volume":"61","author":"TK Kvien","year":"2002","unstructured":"Kvien TK et al. Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension. Ann Rheum Dis 2002; 61: 511\u2013516.","journal-title":"Ann Rheum Dis"},{"key":"BF3302502_CR28","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/art.1780311206","volume":"31","author":"M Gowen","year":"1988","unstructured":"Gowen M, MacDonald BR, Russell RG . Actions of recombinant human gamma-interferon and tumor necrosis factor alpha on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis Rheum 1988; 31: 1500\u20131507.","journal-title":"Arthritis Rheum"},{"key":"BF3302502_CR29","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/0006-291X(89)92243-2","volume":"159","author":"DB Evans","year":"1989","unstructured":"Evans DB, Bunning RA, Van Damme J, Russell RG . Natural human IL-1 beta exhibits regulatory actions on human bone-derived cells in vitro. Biochem Biophys Res Commun 1989; 159: 1242\u20131248.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302502_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/0006-291X(89)92473-X","volume":"160","author":"DB Evans","year":"1989","unstructured":"Evans DB, Bunning RA, Russell RG . The effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on human osteoblast-like cells. Biochem Biophys Res Commun 1989; 160: 588\u2013595.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302502_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0006-291X(90)91932-I","volume":"166","author":"DB Evans","year":"1990","unstructured":"Evans DB, Bunning RA, Russell RG . The effects of recombinant human interleukin-1 beta on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. Biochem Biophys Res Commun 1990; 166: 208\u2013216.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302502_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s002230001167","volume":"68","author":"S Epstein","year":"2001","unstructured":"Epstein S et al. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat. Calcif Tissue Int 2001; 68: 240\u2013247.","journal-title":"Calcif Tissue Int"},{"key":"BF3302502_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/bbrc.1998.9785","volume":"254","author":"EM Awumey","year":"1999","unstructured":"Awumey EM et al. Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption. Biochem Biophys Res Commun 1999; 254: 248\u2013252.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302502_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/17826","volume":"397","author":"L Ulloa","year":"1999","unstructured":"Ulloa L, Doody J, Massague J . Inhibition of transforming growth factor-beta\/SMAD signalling by the interferon-gamma\/STAT pathway. Nature 1999; 397: 710\u2013713.","journal-title":"Nature"},{"key":"BF3302502_CR35","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1046\/j.1365-2443.2002.00599.x","volume":"7","author":"K Miyazawa","year":"2002","unstructured":"Miyazawa K et al. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 2002; 7: 1191\u20131204.","journal-title":"Genes Cells"},{"key":"BF3302502_CR36","doi-asserted-by":"publisher","first-page":"41361","DOI":"10.1074\/jbc.M204597200","volume":"277","author":"M Funaba","year":"2002","unstructured":"Funaba M, Zimmerman CM, Mathews LS . Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 2002; 277: 41361\u201341368.","journal-title":"J Biol Chem"},{"key":"BF3302502_CR37","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1074\/jbc.273.2.677","volume":"273","author":"CM Zimmerman","year":"1998","unstructured":"Zimmerman CM, Kariapper MS, Mathews LS . Smad proteins physically interact with calmodulin. J Biol Chem 1998; 273: 677\u2013680.","journal-title":"J Biol Chem"},{"key":"BF3302502_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0024-3205(02)02244-0","volume":"72","author":"S Kaihara","year":"2002","unstructured":"Kaihara S et al. Effect of FK506 on osteoinduction by recombinant human bone morphogenetic protein-2. Life Sci 2002; 72: 247\u2013256.","journal-title":"Life Sci"},{"key":"BF3302502_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1600-0765.2004.00739.x","volume":"39","author":"CA Nassar","year":"2004","unstructured":"Nassar CA et al. Effect of cyclosporin A on alveolar bone homeostasis in a rat periodontitis model. J Periodontal Res 2004; 39: 143\u2013148.","journal-title":"J Periodontal Res"},{"key":"BF3302502_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","volume":"56","author":"F Lallemand","year":"2003","unstructured":"Lallemand F et al. Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm 2003; 56: 307\u2013318.","journal-title":"Eur J Pharm Biopharm"},{"key":"BF3302502_CR41","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1161\/01.ATV.20.10.2261","volume":"20","author":"W Shi","year":"2000","unstructured":"Shi W et al. Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20: 2261\u20132266.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302502","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:32:06Z","timestamp":1648614726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,7]]},"references-count":41,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2005,8,1]]}},"alternative-id":["BF3302502"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302502","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,7]]},"assertion":[{"value":"13 May 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}